Market Cap: $14.28M
CI
Citius Pharmaceuticals, Inc.
CTXR
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $14.28M
Citius Pharmaceuticals Advances Innovative Treatment Approaches Citius Pharmaceuticals continues to make strides in the development of innovative medicinal solutions, particularly focusing on critical…
Citius Pharmaceuticals Secures $3.8 Million to Advance Critical Care Product Development Citius Pharmaceuticals, Inc. announces a significant financial boost of $3.8 million through New Jersey's Techn…
Citius Pharmaceuticals Secures $3.8 Million Through NOL Program to Advance Critical Care Products Citius Pharmaceuticals, Inc. focuses on developing critical care products and has recently secured $3.…
Citius Pharmaceuticals: Pioneering Progress in Cancer Treatment Citius Pharmaceuticals is making significant strides in the field of oncology, focusing on innovative therapies that address critical ga…
Citius Pharmaceuticals Focuses on Innovative Therapies in Oncology Citius Pharmaceuticals is at the forefront of developing innovative therapies aimed at treating serious medical conditions, particula…
Citius Pharmaceuticals Advances in Clinical Development of Innovative Therapies Citius Pharmaceuticals, a biopharmaceutical company focused on developing innovative therapeutics, is making strides in…
Citius Oncology Strengthens Financial Position for LYMPHIR™ Launch Citius Oncology, Inc., a subsidiary of Citius Pharmaceuticals, Inc., announces a significant strategic initiative aimed at bolstering…
Citius Oncology Amplifies Financial Backbone for LYMPHIR™ Launch Citius Oncology, Inc., a notable subsidiary of Citius Pharmaceuticals, Inc., makes a significant stride in securing its financial found…
Citius Oncology Secures Funding for LYMPHIR™ Launch Citius Oncology, Inc., a subsidiary of Citius Pharmaceuticals, Inc., announces a significant strategic move that aims to strengthen its financial fo…
Citius Pharmaceuticals Fuels Growth with Successful Direct Offering Citius Pharmaceuticals Inc. announces a significant financial development with the successful closing of a registered direct offerin…
Citius Pharmaceuticals Advances Clinical Trials for Innovative Treatments Citius Pharmaceuticals, a company focused on developing innovative therapeutics, is making strides in its clinical trial progr…
Citius Pharmaceuticals Advances in Therapeutic Development Amid Market Uncertainties Citius Pharmaceuticals, a company specializing in innovative therapeutic solutions, continues to make strides in th…
### Citius Pharmaceuticals Advances in Innovative Therapeutics Citius Pharmaceuticals is making significant strides in the development of innovative therapeutics, particularly in the realm of critical…
Citius Pharmaceuticals Strengthens Distribution Network with Cardinal Health Partnership Citius Pharmaceuticals, Inc. enters a pivotal phase in its operational strategy with the announcement of a sign…
Citius Pharmaceuticals Strengthens Distribution Capacity with Key Partnership Citius Pharmaceuticals, Inc. has recently announced a significant distribution services agreement with Cardinal Health, a…